Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucio Cocco

Showing results (231-240 of 238) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 238 results.
Advances in Biological Regulation|November 6, 2019
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cellsShaw M Akula, Saverio Candido, Stephen L Abrams, et al.
Aging|March 23, 2011
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and agingLinda S Steelman, William H Chappell, Stephen L Abrams, et al.
Advances in Biological Regulation|March 23, 2019
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticalsSaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Oncotarget|March 18, 2011
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human healthWilliam H Chappell, Linda S Steelman, Jacquelyn M Long, et al.
Oncotarget|July 23, 2014
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole M Davis, Melissa Sokolosky, Kristin Stadelman, et al.
Current Pharmaceutical Design|March 8, 2016
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for TherapyLinda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, et al.
The New England Journal of Medicine|May 25, 2022
Demethylation and Up-Regulation of an Oncogene after Hypomethylating TherapyYao-Chung Liu, Junsu Kwon, Emiliano Fabiani, et al.
Oncotarget|March 5, 2013
Advances in targeting signal transduction pathwaysJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Pageof 24

Showing results (231-240 of 238) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 238 results.
Advances in Biological Regulation|November 6, 2019
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cellsShaw M Akula, Saverio Candido, Stephen L Abrams, et al.
Aging|March 23, 2011
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and agingLinda S Steelman, William H Chappell, Stephen L Abrams, et al.
Advances in Biological Regulation|March 23, 2019
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticalsSaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Oncotarget|March 18, 2011
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human healthWilliam H Chappell, Linda S Steelman, Jacquelyn M Long, et al.
Oncotarget|July 23, 2014
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole M Davis, Melissa Sokolosky, Kristin Stadelman, et al.
Current Pharmaceutical Design|March 8, 2016
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for TherapyLinda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, et al.
The New England Journal of Medicine|May 25, 2022
Demethylation and Up-Regulation of an Oncogene after Hypomethylating TherapyYao-Chung Liu, Junsu Kwon, Emiliano Fabiani, et al.
Oncotarget|March 5, 2013
Advances in targeting signal transduction pathwaysJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Pageof 24